4.3 Article

The Impact of Radiation Dose on Preoperative Neoadjuvant Chemoradiotherapy Effects for Patients with Locally Advanced Squamous Cell Esophageal Carcinoma: A Propensity Score-Matched Retrospective Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Update on Management of Squamous Cell Esophageal Cancer

John K. Waters et al.

Summary: This review provides a summary of the epidemiology, diagnosis, staging, and treatment of esophageal squamous cell carcinoma (ESCC). Recent findings suggest that novel approaches to screening can be cost-effective in high-incidence regions. Multi-disciplinary evaluation and treatment, including endoscopic resection and minimally invasive esophagectomy, have become the standard of care. Additionally, immunotherapy has shown promising results in improving survival for patients with metastatic or persistent disease.

CURRENT ONCOLOGY REPORTS (2022)

Article Oncology

Predictors of Acute Radiation Dermatitis and Esophagitis in African American Patients Receiving Whole-Breast Radiation Therapy

Stephen Dzul et al.

Summary: Adjuvant whole breast radiation therapy after breast-conserving surgery is the standard of care for early-stage breast cancer. This study found that African American individuals are at higher risk for treatment-related toxic effects and explored factors related to toxic effects, such as breast size and radiation dose.

PRACTICAL RADIATION ONCOLOGY (2022)

Article Oncology

Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

Sehhoon Park et al.

Summary: Durvalumab and tremelimumab combined with definitive concurrent chemoradiotherapy showed promising efficacy in patients with locally advanced esophageal squamous cell carcinoma (ESCC), and PD-L1 expression had strong predictive value in predicting survival outcomes for these patients.

CANCER (2022)

Article Oncology

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)

Maarten C. C. M. Hulshof et al.

Summary: In definitive chemoradiation for esophageal cancer, escalating radiation dose up to 61.6 Gy to the primary tumor did not significantly improve local tumor control compared to 50.4 Gy. The absence of a dose-effect was observed in both adenocarcinoma and squamous cell carcinoma.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

Esophageal and Esophagogastric Junction Cancers, Version 2.2019

Jaffer A. Ajani et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Review Medicine, General & Internal

Oesophageal cancer

Jesper Lagergren et al.

LANCET (2017)

Article Oncology

Cancer Statistics in China, 2015

Wanqing Chen et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Medicine, General & Internal

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

P. van Hagen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Gastroenterology & Hepatology

Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma

Jin Lv et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)